A B S T R A C T
Background: Patients on standard intermittent haemodialysis suffer from strong fluctuations in plasma potassium and phosphate. Prolonged dialysis with a wearable device, based on continuous regeneration of a small volume of dialysate using ion exchangers, could moderate these fluctuations and offer increased clearance of these electrolytes. We report in vivo results on the efficacy of potassium and phosphate adsorption from a wearable dialysis device. We explore whether equilibration of ion exchangers at physiological Ca 2þ , Mg 2þ and hypotonic NaCl can prevent calcium/magnesium adsorption and net sodium release, respectively. Effects on pH and HCO Methods: Healthy goats were instrumented with a central venous catheter and dialysed. Potassium and phosphate were infused to achieve plasma concentrations commonly observed in dialysis patients. An adsorption cartridge containing 80 g sodium poly(styrene-divinylbenzene) sulphonate and 40 g iron oxide hydroxide beads for potassium and phosphate removal, respectively, was incorporated in a dialysate circuit. Sorbents were equilibrated and regenerated with a solution containing NaCl, CaCl 2 and MgCl 2 . Blood was pumped over a dialyser and dialysate was recirculated over the adsorption cartridge in a countercurrent direction. Results: Potassium and phosphate adsorption was 7.7 6 2.7 and 4.9 6 1.3 mmol in 3 h, respectively. Adsorption capacity remained constant during consecutive dialysis sessions and increased with increasing K þ and PO
3À
4 : Equilibration at physiological Ca 2þ and Mg 2þ prevented net adsorption, eliminating the need for post-cartridge calcium and magnesium infusion. Equilibration at hypotonic NaCl prevented net sodium release Fe 2þ and arterial pH did not change. Bicarbonate was adsorbed, which could be prevented by equilibrating at HCO À 3 15 mM. Conclusion: We demonstrate clinically relevant, concentrationdependent, pH-neutral potassium and phosphate removal in vivo with small volumes of regenerable ion exchangers in our prototype wearable dialysis device. Application of the selected ion exchangers for potassium and phosphate removal in a wearable dialysis device appears to be effective with a low-risk profile.
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I N T R O D U C T I O N
Removal of potassium and phosphate is inadequate with conventional thrice-weekly haemodialysis [1, 2] . Due to the intermittency of the treatment, both pre-dialysis hyperkalaemia and post-dialysis hypokalaemia are common in dialysis patients, which may lead to arrhythmias. Insufficient phosphate removal causes bone and cardiovascular problems [3, 4] . Substantial rebound of plasma potassium and phosphate occurs following dialysis [1, 2] . Strict dietary potassium and phosphate restrictions as well as potassium-and phosphate-binding drugs are often required to limit interdialytic increase in these ions. Increasing dialysis dose, by increasing dialysis time and frequency, has been shown to improve potassium and phosphate removal and reduce the need for diet restrictions and oral binders [5] [6] [7] .
A miniature dialysis device that can be used at home would facilitate longer and more frequent dialysis or ideally allow continuous haemodialysis, and may thereby improve potassium and phosphate balance. The miniaturization can be achieved by continuous regeneration of a small volume of dialysate by adsorption [8] [9] [10] [11] [12] [13] . Previously, we showed that in vitro removal of potassium and phosphate could achieve clinically relevant levels by use of the ion exchangers poly(styrene-divinylbenzene)sulphonate and iron oxide hydroxide (FeOOH) incorporated in a miniature artificial kidney device [14] . Here, we study in vivo efficacy of potassium and phosphate removal by the device in healthy goats and investigated whether removal was dependent on plasma concentrations. Potassium and phosphate were infused to achieve plasma concentrations close to the ranges observed in dialysis patients. First, we studied the effect on plasma calcium and magnesium concentrations because we observed in vitro that the sorbents bind both calcium and magnesium; we could prevent this problem by pre-rinsing the sorbents with a solution containing calcium and magnesium, which we now test here in vivo. Second, we observed in vitro equimolar exchange of potassium for sodium when pre-rinsing the sorbents with sodium chloride 154 mM; we now explore whether sodium release can be reduced by pre-rinsing at a lower sodium concentration. Third, because we used an iron-containing sorbent to bind phosphate, we determined whether in vivo exposure to this sorbent affected plasma iron concentration. Finally, we studied the effect on plasma pH and HCO À 3 to confirm the neutral acid-base properties of the sorbents that we observed in vitro [14] .
M A T E R I A L S A N D M E T H O D S

Materials
A miniature dialysis device of 1.5 kg (plus battery pack of 250 g for 3 h of dialysis) was built and provided by Nanodialysis (Oirschot, The Netherlands) as described [14] . Eighty grams of poly(styrene-divinylbenzene) sulphonate beads and 40 g FeOOH beads (together 120 g in a dry and 161 g in a wet state) were incorporated in the adsorption cartridge of the device for respective potassium and phosphate removal [14] . Highflux dialysers (Polyflux 2H 0.2 m 2 ; Gambro Dialysatoren, Hechingen, Germany) were used to separate blood and dialysate. Thomas pumps (Gardner Denver Thomas, Sheboygan, WI, USA) were applied [14] .
A 72-cm double-lumen central venous catheter (CVC) was selected for haemodialysis (Palindrome Chronic Dialysis Catheter, Covidien, Zaltbommel, The Netherlands). Unfractionated heparin was used for anticoagulation.
Methods
Animals. In vivo experiments were approved by the Animal Experiments Committee (Utrecht, The Netherlands) and performed in accordance with national guidelines for the care and handling of animals. Healthy Dutch White goats (n ¼ 2) were selected since these animals are docile, have easily accessible neck veins and have body weights (70-90 kg) and distribution volumes comparable with humans.
Sterilization and regeneration procedure. In each experiment, new sterile tubing and dialyser were used. Prior to each experiment, the sorbents were sterilized in a sterile environment by 1-h exposure of the internal fluidic circuit to 1 L 5% hydrogen peroxide (m/m) and 0.2% peracetic acid (m/m) in NaCl 120 mM/CaCl 2 1.2 mM/MgCl 2 0.45 mM, followed by 12-h exposure to 1 L NaOH 120 mM/ethanol 20% (v/v). This procedure was shown to be effective in eliminating bacteria and endotoxins. Subsequently, pH was adjusted to a physiological range using 1 L NaCl 120 mM/HCl 50 mM, followed by rinsing and equilibration of the sorbents with 3 L rinsing 2 and MgCl 2 and in seven experiments also NaHCO 3 . Equilibration was achieved by recirculating the rinsing solution in the blood circuit at 110 mL/min while draining the solution from the dialysate circuit at 40 mL/min and measuring calcium in the effluent (equilibration of calcium is slower than that of other relevant electrolytes). The rinsing procedure was continued until inlet and outlet calcium concentrations levelled (usually after circulation of 3 L of rinsing solution). The sodium concentration of the rinsing solution was 120 mM based on prior in vitro experiments, showing no net sodium release at this concentration. CaCl 2 and MgCl 2 concentrations were optimized during the experiments of the current study. Net changes in total plasma calcium and magnesium were minimal at Ca 2þ 1.2 mM and Mg 2þ 0.40-0.45 mM, respectively (Supplementary data, Figures S1 and S2). Data shown in the Results section on calcium and magnesium balance were obtained with these rinsing solution concentrations (n ¼ 6 experiments for Ca 2þ 1.2 mM and n ¼ 7 for Mg 2þ 0.40-0.45 mM). In the first 7 of 14 experiments, no bicarbonate was added to the rinsing solution. In the last two of these seven experiments, bicarbonate was measured downstream of the dialyser. Since the net bicarbonate adsorption across the dialyser occurred, NaHCO 3 was added to the rinsing solution in the last seven experiments to obtain a HCO À 3 of 15 mM (thus, in the first seven experiments, NaCl 120 mM was applied and in the last seven, NaCl 105 mM/NaHCO 3 15 mM was used).
Supplementary data, Table S1 shows the composition of the rinsing solution per experiment.
Experimental procedure. Fourteen experiments were performed in two goats (n ¼ 6 and 8, respectively). Goats were temporarily sedated (with detomidine and propofol) to insert a CVC in the jugular vein. A catheter was placed in the auricular artery for arterial pressure measurement and withdrawal of arterial blood gases. The dialysate circuit was filled with $100 mL rinsing solution. Blood lines were connected and blood was pumped (110 mL/min) over the dialyser ( Figure 1 ).
After 30 min habituation of the goat and equilibration of blood with the dialysate compartment, the dialysate pump was started and dialysate was recirculated (40 mL/min) during 3 h over the adsorption cartridge ( Figure 2 ) in the countercurrent direction (prior experiments showed that higher pump speeds did not improve potassium and phosphate removal, thus 40 mL/min was applied to keep energy consumption low). Blood and dialysate samples were taken hourly from the blood circuit (down-and upstream of the dialyser), from the dialysate circuit (down-and upstream of the adsorption cartridge) and from the arterial catheter. K þ , PO 3À 4 ; total Ca, total Mg, Fe 2þ , albumin, Na þ , HCO À 3 and arterial pH were monitored. At the end of each experiment, the catheters were removed. In one experiment, no arterial blood gases were drawn because placement of the catheter in the auricular artery failed. Of note, during six experiments, electro-oxidation was applied for urea removal [15] . Electro-oxidation influenced neither potassium/phosphate adsorption nor the acid-base findings reported below (data not shown).
Spontaneous systemic potassium and phosphate concentrations in the goats were 3.9 6 0.3 and 1.5 6 0.3 mM, respectively. To achieve higher potassium and phosphate plasma concentrations closer to the range commonly observed in dialysis patients, we infused potassium and phosphate [15] using a 1 M KCl solution at 0-45 mL/h and a 0.05 M Na 2 HPO 4 /0.25 M KH 2 PO 4 solution at 0-25 mL/h in eight experiments. Infusion rates were adjusted depending on plasma potassium and phosphate concentrations, aiming for K þ 4-5.5 mM and PO 3À 4 1.6-3.0 mM, respectively [16] (Supplementary data, Figure S3 ). To test regenerability, nine consecutive experiments were performed with the same adsorption cartridge while sterilizing, regenerating and equilibrating the cartridge between the experiments (see the Sterilization and regeneration procedure section).
Anticoagulation strategy. After insertion of the CVC, a bolus of unfractionated heparin was given (10 000 IU), followed by continuous infusion of $3500 IU/h. The activated clotting time (ACT) was measured every hour and the heparin dose adjusted, aiming for an ACT >500 s. One hour before removal of the CVC, heparin infusion was stopped to allow coagulation to recover.
Laboratory measurements. All electrolyte measurements were performed by the laboratory of the University Medical Center Utrecht. Potassium, phosphate, sodium, calcium, magnesium, venous bicarbonate, albumin and iron concentrations were analysed with an AU 5800 routine chemistry analyser (Beckman Coulter, Brea, CA, USA) using ion-selective 
. Arterial blood gas analyses were performed using a blood gas analyser (Rapidlab type 1265; Siemens Medical Solutions Diagnostics, Breda, The Netherlands).
Calculations, analyses and statistics. Removal/release of electrolytes to or from plasma was calculated using the following formula:
and removal/release to or from dialysate:
where A is the amount removed (or released) (mmol) from (or into) plasma (A p ) or dialysate (A d ), C i is the inlet plasma concentration (i.e. upstream of dialyser) or inlet dialysate concentration (i.e. upstream of adsorption unit) (mmol/L), C o is the outlet plasma or dialysate concentration (mmol/L), t is the time after start of the dialysate pump (min) (Figure 2) , Q is the blood or dialysate flow (L/min), Dt ¼ t2Àt1 and Ht is hematocrit.
Removal data are presented as the average removal from plasma and dialysate (A):
Plasma calcium levels were corrected for albumin:
The change in plasma iron levels across the dialyser (measurements performed at the start and end of each experiment) was quantified as
For investigation of the concentration-dependency of potassium and phosphate removal, cumulative 3-h removal was related to the average inlet plasma concentrations during the 3-h experiment.
Data are shown as mean 6 SD. Linear interpolation was used for 13% of the acid-base measurements (7 of 52) where data were missing. Missing data were all at 120 min, one per experiment for seven experiments.
Statistical significance was determined using (paired) t-tests and linear regression analysis. For comparison of absolute removal, one-way analysis of variance testing with post hoc correction using Tukey's multiple comparisons test was applied.
R E S U L T S
Potassium and phosphate removal
Cumulative removal in 3 h was 7.7 6 2.7 mmol potassium (n ¼ 14; 96 6 34 mmol/g sorbent) at plasma K þ 4.1 6 0.9 mM ( Figure 3A ) and 4.9 6 1.3 mmol phosphate (n ¼ 14; 123 6 32 mmol/g sorbent) at plasma PO 3À 4 2.1 6 0.5 mM ( Figure 3B ). The adsorption rate decreased gradually, with an absolute potassium removal of 4.5 6 1.8 mmol in the first hour, 2.4 6 1.0 mmol in the second hour and 0.8 6 0.7 mmol in the third hour (P < 0.001) and an absolute phosphate removal of 2.4 6 0.7 mmol in the first hour, 1.6 6 0.5 mmol in the second hour and 0.8 6 0.4 mmol in the third hour (P < 0.001).
Adsorption of both potassium and phosphate was clearly concentration dependent ( Figure 3C and D) . Linear regression analysis shows that with every mmol/L increase in plasma K þ or plasma PO 3À 4 upstream of the dialyser, 3-h removal increases with roughly 2.6 mmol potassium or 2.1 mmol phosphate, respectively.
Overall, 3-h adsorption capacity during consecutive dialysis sessions did not show a significant decline after regeneration and reuse of the same adsorption cartridge ( Figure 3E and F), although variation in potassium and phosphate concentrations might mask a small decrease in binding capacity with increasing regeneration cycles.
Influence on calcium and magnesium concentrations and balance
When equilibrating the sorbents at Ca 2þ 1.2 mM (n ¼ 6) and Mg 2þ 0.40-0.45 mM (n ¼ 7), systemic plasma concentrations of calcium and magnesium measured upstream of the dialyser remained stable ( Figure 4A) . A limited release of calcium was measured across the dialyser ( Figure 4B ; 0.52 6 0.46 mmol calcium in 3 h), although no significant differences were observed between average calcium concentrations up-and downstream of the dialyser (plasma) or adsorption cartridge (dialysate) ( Figure 4C ). No net change in magnesium balance was detected in 3 h (Figure 4B and D) .
Influence on plasma sodium concentrations and balance
Rinsing solution with a sodium concentration of 120 mM (n ¼ 14) did not significantly change the systemic plasma Na þ during the experiments, and no net sodium release was detected ( Figure 5A-D) .
Influence on plasma iron concentrations and balance
There was no net adsorption of iron across the dialyser and also no release from the iron-containing phosphate sorbent [average concentration change across the dialyser (downstream minus upstream): À0.44 6 1.58 lmol/L; P ¼ 0.81]. No iron was detected in the dialysate.
Influences on acid-base status
The average arterial blood pH at the start of the experiments was 7.44 6 0.04 (n ¼ 13). Linear regression analysis did not show a significant change of arterial pH and plasma bicarbonate concentrations over time ( Figure 6A Figure S4 ), no net release or adsorption was detected when the dialyser was pre-rinsed with 15 mM bicarbonate (Figure 6C and D; n ¼ 7).
Vital parameters before, during and after dialysis
Other than a parallel rise in blood pressure and pulse rate, which was probably due to increasing sympathetic tone in the restrained goats during the course of the experiment (while the effect of the sedatives was wearing off), no relevant adverse effects were observed during the experiments (Supplementary data, Table S2 ).
D I S C U S S I O N
In this study, we demonstrate clinically relevant, plasma concentration-dependent removal of potassium and phosphate by a miniature dialysis device in awake non-uraemic goats. Potassium and phosphate removal was achieved through adsorption from a dialysate circuit by a cartridge containing ion exchangers [poly(styrene-divinylbenzene) sulphonate and FeOOH for potassium and phosphate removal, respectively]. Net adsorption of calcium and magnesium by the ion exchangers was prevented by pre-rinsing with a calcium-and magnesium-containing solution. No relevant adverse effects were observed during the experiments. Our study shows that a cartridge containing a mixture of 80 g of poly(styrene-divinylbenzene) sulphonate and 40 g of FeOOH beads can remove 7.7 6 2.7 mmol potassium (96 6 34 mmol/g sorbent) at an average plasma K þ of 4.1 6 0.9 mM and 4.9 6 1.3 mmol phosphate (123 6 32 mmol/g sorbent) of phosphate at an average plasma PO 3À 4 of 2.1 6 0.5 mM during 3 h in vivo. These numbers are comparable with previously reported in vitro removal [14] (97 6 19 mmol potassium/g sorbent at K þ 3.8 6 1.0 mM; 86 6 10 mmol phosphate/g sorbent at PO 3À 4 1.8 6 0.4 mM). Of note, we assumed a linear decrease in adsorption rate during the interval between two sampling times and might therefore have overestimated the adsorbed amount to some extent. Note that the 14 experiments reported in this study were performed on two goats (6 in one and 8 in the other). Saturation of the sorbents occurred, resulting in a potassium and phosphate removal of only approximately one-fifth and approximately one-third in the third hour when compared with the first hour of treatment. To remove the daily load of potassium and phosphate (45 and 15 mmol, respectively, assuming that the intake of patients dependent on dialysis is 25% less than that of healthy individuals [17] [18] [19] ), extending the length of dialysis with the same adsorption cartridge will therefore not be very effective. Consequently, the amount of sorbent would have to be increased to achieve removal of the daily load. To compete with intermittent (thrice-weekly), 4- [20, 21] , respectively, the total weight of the sorbents in the dialysis device would have to be increased to $830-1160 g. It should be noted that we have shown in vitro that saturated cartridges containing poly(styrenedivinylbenzene) sulphonate and FeOOH can be regenerated [14] . The present study indicates that the repetitive use of the same adsorption cartridge does not compromise removal capacity in vivo, thereby facilitating reuse and limiting costs. To reduce device weight, saturated intermediate-size adsorption cartridges could be replaced by regenerated cartridges several times per day.
Currently, we use a rather large volume of aqueous solutions for the sterilization and regeneration procedure ($6-6.5 L for sterilization, regeneration and dialysate), but this volume might be considerably reduced by using alternative sterilization techniques, optimizing the equilibration procedure and centralizing the procedure. Optimization of this procedure is the focus of future research and is also dependent on other components of the device (e.g. the currently applied electronic sensors are not compatible with c radiation). Nevertheless, there is already a large difference between the volumes currently needed for our device and those used in conventional haemodialysis ($120 L of dialysate per session plus varying amounts of fluid used for rinsing of the dialysis machine and reject fluid resulting from . Our methodology will be beneficial in terms of ecological and economic perspectives for situations where water is scarce or expensive (e.g. in some developing countries).
Importantly, the binding capacity of the sorbents is highly concentration dependent: per mmol plasma potassium and phosphate increment, the 3-h removal increases by 2.6 and 2.1 mmol, respectively. This concentration dependency is a valuable safety characteristic of the device, since this implies that the lower the concentration, less is removed, and vice versa. Consequently, risks of extreme levels of potassium and phosphate are attenuated. Based on this predictive relationship, expected removal and its effect on plasma concentrations can be calculated at the start of each dialysis session, making this an intrinsically safe mode of operation.
Both poly(styrene-divinylbenzene) sulphonate and FeOOH can bind significant amounts of calcium and magnesium. Equilibrating the sorbents with a rinsing solution containing relatively high calcium and magnesium concentrations was shown to prevent this absorption in vitro, even inducing some release of these electrolytes [14] . In the current in vivo study, equilibrating the sorbents with a rinsing solution with lower calcium and magnesium concentrations (close to the respective ionized plasma concentrations) resulted in negligible calcium release and prevention of net magnesium release and adsorption. Interestingly, our results suggest that the net balance of calcium and magnesium could be regulated in an individualized fashion by altering their concentration in the rinsing solution. For example, a net negative calcium balance may be induced in patients using calcium-containing phosphate binders by using a rinsing solution with a low calcium concentration. In vitro experiments showed that calcium and magnesium pre-rinsing did not affect the potassium-binding capacity of the sorbents (data not shown).
In vitro, we found that poly(styrene-divinylbenzene) sulphonate binds potassium in exchange for sodium in an equimolar fashion [14] . Equilibrating the adsorption cartridge at a low sodium concentration resulted in no net measurable change of inlet and outlet plasma and dialysate sodium concentrations during the 3-h in vivo experiments; the mechanism is unclear. We hypothesize that net sodium release, resulting from exchange of potassium for sodium, is prevented by simultaneous exchange of sodium for hydrogen. Hydrogen may subsequently combine with hydroxyl ions (released in exchange for phosphate from the FeOOH beads) to form water or with bicarbonate to form water and carbon dioxide. The latter would partly explain bicarbonate removal (prevented by prerinsing with bicarbonate) [8] [9] [10] 22] .
The phosphate sorbent FeOOH could theoretically release iron into the dialysate and the patient. The findings that the plasma dialyser inlet and outlet iron concentrations did not change and no iron was detected in the dialysate argue against significant iron release by the adsorption cartridge. Whether significant changes in iron stores occur after long-term use of the sorbent and exposure to trace concentrations of iron remains to be determined.
Some of the potassium or phosphate sorbents tested in our in vitro experiments had either marked acidifying (zirconium phosphate and carbonate) or alkalizing (zeolite, sevelamer carbonate) effects, whereas the two sorbents used in the current study were shown to be acid-base neutral [14] . However, the in vivo study showed that bicarbonate was adsorbed, probably by FeOOH, which was not detected in the in vitro studies because bicarbonate-containing solutions were not applied in the static binding tests. The bicarbonate removal could be prevented by equilibrating the sorbents with bicarbonate 15 mM.
Our sorbent unit may have some advantages over the (modified) REDY system, which is currently the only dialysateregenerating system applied in trials with wearable dialysis devices [8-10, 12, 13, 22] . Although the binding capacity of the REDY sorbents (zirconium salts) is higher than that of our sorbents, our sorbents can be regenerated, which reduces overall costs of the miniature dialysis device. As shown in our in vitro experiments, the sorbents of the REDY system cannot be easily regenerated [14] . Furthermore, because zirconium phosphate removes all calcium and magnesium, the REDY system relies on post-cartridge infusion of these electrolytes to maintain stable plasma levels. As described, there is no adsorption of calcium and magnesium in our device when pre-rinsing with these electrolytes, and thus no need for reinfusion.
To offer a realistic alternative for regular dialysis, additional techniques would have to be incorporated in this miniature dialysis device to remove other toxins, such as activated carbon for organic waste solutes and possibly electro-oxidation for urea removal [15] . In addition, it will require much effort to translate these promising in vivo results to safe application of the selected sorbents in a wearable dialysis device in patients. The familiarity of clinicians with a low toxicity profile of the sorbents in the current study should facilitate acceptance for clinical purposes [14, 23] .
Conclusions
Clinically relevant potassium and phosphate removal from plasma was achieved in vivo by use of 80 g of poly(styrenedivinylbenzene) sulphonate and 40 g of FeOOH beads. Removal is concentration dependent, which can be regarded as an intrinsic safety feature of the device, facilitating introduction in maintenance dialysis. Net calcium and magnesium adsorption can be prevented by pre-rinsing the sorbents with these electrolytes, thereby eliminating the need for extra infusion. Importantly, this miniature dialysis system shows no sodium release in vivo and there are no effects on arterial pH and bicarbonate levels if the sorbents are pre-rinsed with bicarbonate.
S U P P L E M E N T A R Y D A T A
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